![Michael Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Baker
Verkställande Direktör på
PERCHERON THERAPEUTICS LIMITED
Förmögenhet: 351 933 $ per 2026-08-31
Profil
Dr. Michael Baker is a Chief Executive Officer & Managing Director at Percheron Therapeutics Ltd. and an Investment Associate at Bioscience Managers Pty Ltd. He is on the Board of Directors at Radiopharm Theranostics (USA), Inc. Dr. Baker was previously employed as an Independent Non-Executive Director by Radiopharm Theranostics Ltd., a Chief Executive Officer, MD & Director by Arovella Therapeutics Ltd., and a Senior Manager by Hexima Ltd. He received his undergraduate degree from La Trobe University, a graduate degree from La Trobe University and an MBA from Melbourne Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-04 | 8 184 493 ( 0,68 % ) | 351 933 $ | 2026-08-31 |
Aktiva positioner av Michael Baker
| Företag | Position | Start |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Verkställande Direktör | 2026-10-05 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity-analytiker | 2017-11-01 |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Michael Baker
| Företag | Position | Slut |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Verkställande Direktör | 2026-05-04 |
| RADIOPHARM THERANOSTICS LIMITED | Direktör/Styrelseledamot | 2024-03-26 |
| HEXIMA LIMITED | Företagsledare/Principal | - |
Michael Bakers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
70
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Melbourne Business School
 Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hexima Ltd.
 Hexima Ltd. BiotechnologyHealth Technology Engages in research and development of plant-derived proteins for treatment of fungal nail infections and provides commercial property services | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
LaTrobe University
 LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
Radiopharm Theranostics (USA), Inc.
Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical products for diagnostic and therapeutic uses | Health Technology |
